James Andrea S. 4
4 · Insight Molecular Diagnostics Inc. · Filed Sep 30, 2025
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Award
Option to Purchase Common Stock
2025-09-28+235,000→ 235,000 totalExercise: $3.33Exp: 2035-09-28→ Common Stock (235,000 underlying)
Footnotes (1)
- [F1]33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.